Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 84.87% is in line with its 5-year average of 88.79%, near the low end of its 5-year range (84.87%–91.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.74% below its 12-month average of 88.17%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
84.87%
GROSS MARGIN AVG TTM
88.17%
GROSS MARGIN AVG 3Y
89.70%
GROSS MARGIN AVG 5Y
88.79%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.74%
CURRENT VS 3Y AVG
-5.39%
CURRENT VS 5Y AVG
-4.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
60.23%
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+40.91%
vs the sector median at left
Market Cap
$3.17B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$7.06B
Gross Margin
73.84%
TTM Avg
76.65%
3Y Avg
78.21%
5Y Avg
76.94%
Market Cap
$2.21B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$7.79B
Gross Margin
14.38%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
Market Cap
$1.16B
Gross Margin
73.53%
TTM Avg
70.13%
3Y Avg
70.04%
5Y Avg
68.74%
Market Cap
$441.10M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Doximity, Inc. (DOCS) | $4.79B | 84.87% | 88.17% | 89.70% | 88.79% |
| TransMedics Group, Inc. (TMDX)vs › | $3.17B | 58.69% | 59.64% | 63.22% | 64.62% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 73.84% | 76.65% | 78.21% | 76.94% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 49.52% | 50.81% | 52.12% | 52.25% |
| Oscar Health, Inc. (OSCR)vs › | $7.79B | 14.38% | 17.24% | 38.82% | 59.22% |
| Teladoc Health, Inc. (TDOC)vs › | $1.16B | 73.53% | 70.13% | 70.04% | 68.74% |
| NRC Health (NRC)vs › | $496.03M | 56.33% | 58.27% | 60.30% | 61.48% |
| Shoulder Innovations, Inc. (SI)vs › | $441.10M | 77.34% | 76.74% | 77.57% | 77.57% |
| Insulet Corp. (PODD)vs › | $9.93B | 71.08% | 70.71% | 67.87% | 67.39% |
| Henry Schein, Inc. (HSIC)vs › | $10.28B | 30.31% | 29.43% | 29.32% | 29.12% |
Gross Margin
84.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 84.87% |
| 2026-03-31 | 86.65% |
| 2025-12-31 | 89.89% |
| 2025-09-30 | 90.25% |
| 2025-06-30 | 89.18% |
| 2025-03-31 | 89.54% |
| 2024-12-31 | 91.59% |
| 2024-09-30 | 90.01% |
| 2024-06-30 | 89.30% |
| 2024-03-31 | 89.36% |
| 2023-12-31 | 90.99% |
| 2023-09-30 | 88.77% |
| 2023-06-30 | 87.87% |
| 2023-03-31 | 87.67% |
| 2022-12-31 | 88.26% |
| 2022-09-30 | 87.07% |
| 2022-06-30 | 85.57% |
| 2022-03-31 | 87.44% |
| 2021-12-31 | 88.67% |
| 2021-09-30 | 88.72% |
| 2021-06-30 | 89.01% |
| 2021-03-31 | 88.01% |
| 2020-12-31 | 86.59% |
| 2020-09-30 | 83.47% |
| 2020-06-30 | 78.36% |
| 2020-03-31 | 88.22% |
| 2019-12-31 | 88.34% |
